Norwood Felicia F's Form 4 filing
Elevance Health, Inc.ELV · filed Apr 25, 2024
- Accession no.
- 0001415889-24-011527
- Filed
- Apr 25, 2024
- Trade date
- Apr 23-24, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Norwood Felicia FCIK 0001743548 | Officer (EVP & President,Gov Health Ben) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 | Common Stock | MOption exerciseAcquired | +5,473 | $238.27 | +$1,304,051.71 | 45,571 | Direct | |
| Apr 23, 2024 | Common Stock | SSaleDisposed | −14,011 | $533.73F1 | −$7,478,091.03 | 31,560 | Direct | |
| Apr 23, 2024 | Common Stock | SSaleDisposed | −100 | $534.74 | −$53,474 | 31,460 | Direct | |
| Apr 24, 2024 | Common Stock | MOption exerciseAcquired | +2,043 | $238.27 | +$486,785.61 | 33,503 | Direct | |
| Apr 24, 2024 | Common Stock | SSaleDisposed | −2,765 | $532.14F2 | −$1,471,367.1 | 30,738 | Direct | |
| Apr 24, 2024 | Common Stock | SSaleDisposed | −3,434 | $532.68F3 | −$1,829,223.12 | 27,304 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 | Common Stock | MOption exerciseDisposed | −5,473 | $0.00 | $0 | 2,043 | Direct | |
| Apr 24, 2024 | Common Stock | MOption exerciseDisposed | −2,043 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $531.44 to $532.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $532.44 to $533.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.